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background:  It is known that elevated levels of unbound free fatty acids (FFAu) are early markers of acute myocardial ischemia, whereas elevated 
myoglobin (MYO) levels within a few hours after onset of acute coronary syndromes predict adverse outcomes . We sought to evaluate the predictive 
accuracy of FFA and MYO combined in a non-selected cohort of patients with non-ST elevation acute coronary syndromes (NSTEACS)
methods: We enrolled 230 consecutive NSTEACS patients treated at 19 centers. Plasma levels of FFAu were assessed on admission by fluorometry 
(FFA Sciences, San Diego, CA). MYO,CK MB Mass and Troponin T were analyzed by electrochemiluminiscense at an independent central core 
laboratory. Cutoff values were 5 nM/ml for FFA, 110 ng/ml for MYO, 5 ng/ml for CK MB Mass, and 0,03 ng/ml for troponin T. The outcome measure 
was death/(re) acute myocardial infarction (AMI) at 30 day follow-up.
results: Mean age was 64 ± 13 years old, 29 % were female, 19% were diabetic, 70% had hypertension, 25% were smokers, 38% had dyslipidemia 
and 27% had prior AMI. Median (25th, 75th) time from symptom onset to sample collection was 4 hours (2, 7.5). FFAu - MYO were elevated in 21% 
of patients. The primary outcome occurred more often in patients with elevated FFAu - MYO on admission (10% vs 2.8%, 2p < 0.0001. After adjusting 
for age, dyslipidemia, ST deviation, CK MB mass, Troponin T,elevated FFAu-MYO remained an independent predictor of 30-day death/AMI [OR 95%CI: 
4.6 (1.2-17) 2p: 0.02].
Conclusion: Within the first hours of symptoms onset, FFAu and MYO predict adverse outcomes in NSTEACS. This observation should be considered 
for future investigations for early and rapid risk stratification in patients with NSTEACS.
